Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Change in Receivables (2023 - 2025)

Metagenomi (MGX) has disclosed Change in Receivables for 3 consecutive years, with -$655000.0 as the latest value for Q4 2025.

  • Quarterly Change in Receivables fell 198.05% to -$655000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$952000.0 through Dec 2025, up 20.27% year-over-year, with the annual reading at -$952000.0 for FY2025, 20.27% up from the prior year.
  • Change in Receivables for Q4 2025 was -$655000.0 at Metagenomi, down from $87000.0 in the prior quarter.
  • The five-year high for Change in Receivables was $1.6 million in Q3 2023, with the low at -$1.5 million in Q4 2023.
  • Average Change in Receivables over 3 years is -$202300.0, with a median of -$307000.0 recorded in 2024.
  • The sharpest move saw Change in Receivables surged 145.35% in 2024, then tumbled 198.05% in 2025.
  • Over 3 years, Change in Receivables stood at -$1.5 million in 2023, then soared by 145.35% to $668000.0 in 2024, then crashed by 198.05% to -$655000.0 in 2025.
  • According to Business Quant data, Change in Receivables over the past three periods came in at -$655000.0, $87000.0, and -$139000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.